Inlyta

Active Ingredient(s): Axitinib
FDA Approved: * January 27, 2012
Pharm Company: * PFIZER
Category: Cancer

Axitinib, sold under the brand name Inlyta, is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models[3] and has shown partial responses in clinical trials with renal cell carcinoma (RCC)[4] and several other tumour types.[5] It was approved to treat renal cell carcinoma by the U.S. Food and Drug Administration after showing a modest increase... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Inlyta Pfizer;1;XNB
Inlyta 1 mg Oral Tablet
NDC: 0069-0145
Labeler:
Pfizer Laboratories Div Pfizer Inc
Inlyta Pfizer;5;XNB
Inlyta 5 mg Oral Tablet
NDC: 0069-0151
Labeler:
Pfizer Laboratories Div Pfizer Inc
Inlyta Pfizer;5;XNB
Inlyta 5 mg Oral Tablet, Film Coated
NDC: 63539-044
Labeler:
U.S. Pharmaceuticals
Inlyta 1 mg Oral Tablet, Film Coated
NDC: 63539-026
Labeler:
U.S. Pharmaceuticals